Double maintains 3 strategies that include ARWR - Arrowhead Pharmaceuticals, Inc.
Yahoo
The global chronic hepatitis B market is experiencing growth due to breakthroughs in diagnosis and treatment, including gene-editing and immune modulation therapies. With therapies advancing towards regulatory approval, the market is poised for expansion from 2025 to 2035. The sector's evolution is driven by increased awareness and advanced healthcare infrastructure, particularly in North America. However, challenges such as high treatment costs and limited access in endemic regions remain. Key
Yahoo
PASADENA, Calif., June 23, 2025--Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has completed enrollment in SHASTA-3, SHASTA-4, and MUIR-3, the company’s global Phase 3 clinical studies designed to support regulatory submissions for marketing approval of investigational plozasiran in the treatment of severe hypertriglyceridemia. Arrowhead anticipates completing the primary portion of these studies in mid-2026 with topline data expected shortly thereafter and planned submi
Finnhub
Presenter SpeechAndrea Tan Great. Thanks, everyone, for joining us. I'm Andrea Newkirk, one of the biotech analysts here at Goldman Sachs, and I'm really pleased to be joined by James Hamilton, CMO...
Finnhub
ARO-C3, an investigational RNAi Therapeutic Targeting Complement C3, Reduces Proteinuria, Hematuria, and Complement Activity in IgAN Patients ...
Yahoo
We recently published a list of Jim Cramer’s Thoughts on These 12 Stocks. In this article, we are going to take a look at where Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR) stands against other stocks that Jim Cramer discusses. When a caller inquired about Arrowhead Pharmaceuticals, Inc. (NASDAQ:ARWR), Cramer said: “You know, look, it doesn’t make any […]
Yahoo
The trial will initially involve healthy obese people receiving single and multiple escalating doses of the therapy.
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| MKTX | -0.18% | $8.22B | +9.03% | 1.38% |
| DUK | 0.18% | $90.99B | +17.25% | 3.56% |
| MOH | -0.22% | $12.95B | -19.36% | 0.00% |
| MSEX | -0.25% | $1.00B | +5.97% | 2.41% |
| IMDX | 0.27% | $86.94M | -0.65% | 0.00% |
| LTM | 0.29% | $12.63B | -95.46% | 2.42% |
| MO | 0.36% | $99.67B | +28.77% | 6.90% |
| AQB | 0.54% | $2.96M | -53.35% | 0.00% |
| NOC | 0.70% | $71.81B | +14.14% | 1.69% |
| OCFT | -0.74% | $267.49M | +332.74% | 0.00% |
| UNH | 1.05% | $279.00B | -37.22% | 2.74% |
| AEP | -1.09% | $55.16B | +17.93% | 3.54% |
| T | 1.18% | $203.71B | +51.55% | 3.92% |
| SO | 1.31% | $100.18B | +17.28% | 3.18% |
| DRD | 1.38% | $1.18B | +51.33% | 2.03% |
| SRRK | 1.42% | $3.38B | +357.53% | 0.00% |
| GFI | 1.57% | $21.56B | +57.55% | 2.31% |
| AMT | 1.85% | $104.32B | +14.40% | 3.00% |
| ACI | 1.90% | $12.40B | +10.61% | 2.47% |
| UUU | 1.90% | $7.17M | +101.30% | 0.00% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| WEAT | -0.08% | $117.15M | 0.28% |
| BSV | -0.10% | $38.39B | 0.03% |
| XBIL | -0.18% | $783.90M | 0.15% |
| KCCA | -0.21% | $109.43M | 0.87% |
| USFR | -0.37% | $18.56B | 0.15% |
| FTSM | -0.45% | $6.37B | 0.45% |
| IBTP | -0.64% | $143.92M | 0.07% |
| FXE | 0.74% | $568.94M | 0.4% |
| BUXX | -0.81% | $315.18M | 0.25% |
| IEF | -0.82% | $34.88B | 0.15% |
| LGOV | 0.85% | $678.86M | 0.67% |
| BOXX | 0.93% | $6.80B | 0.19% |
| CMBS | -0.94% | $449.66M | 0.25% |
| STIP | -1.25% | $12.72B | 0.03% |
| BSMW | -1.38% | $107.45M | 0.18% |
| JMST | 1.39% | $4.06B | 0.18% |
| GOVI | 1.46% | $929.28M | 0.15% |
| UTEN | -1.50% | $210.24M | 0.15% |
| CANE | 1.79% | $10.37M | 0.29% |
| SGOV | 1.82% | $49.21B | 0.09% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| DNLI | 57.99% | $2.16B | -30.05% | 0.00% |
| IMNM | 56.58% | $750.92M | -28.80% | 0.00% |
| BEAM | 54.02% | $2.00B | -15.33% | 0.00% |
| RGNX | 53.91% | $434.35M | -20.33% | 0.00% |
| YMAB | 52.52% | $192.96M | -62.57% | 0.00% |
| BN | 51.30% | $103.22B | +45.48% | 0.54% |
| BNT | 50.65% | $12.59B | +45.18% | 0.00% |
| COGT | 50.62% | $843.67M | -11.36% | 0.00% |
| OCUL | 50.52% | $1.51B | +41.41% | 0.00% |
| RXRX | 50.11% | $2.12B | -29.12% | 0.00% |
| VSH | 49.90% | $2.31B | -23.47% | 2.34% |
| AMBA | 49.74% | $2.81B | +16.04% | 0.00% |
| NTLA | 49.44% | $1.11B | -53.25% | 0.00% |
| CRNX | 48.75% | $2.76B | -33.39% | 0.00% |
| KN | 48.40% | $1.57B | +6.47% | 0.00% |
| NDAQ | 48.29% | $51.40B | +48.85% | 1.10% |
| SYRE | 48.09% | $935.48M | -39.83% | 0.00% |
| IONS | 48.06% | $6.94B | -4.41% | 0.00% |
| NCZ | 48.01% | - | - | 6.30% |
| MCHP | 47.82% | $39.46B | -21.82% | 2.45% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| GNOM | 67.79% | $44.57M | 0.5% |
| XBI | 65.70% | $4.82B | 0.35% |
| IBB | 62.03% | $5.26B | 0.45% |
| ARKG | 57.31% | $1.02B | 0.75% |
| KJUL | 57.26% | $119.50M | 0.79% |
| IWC | 56.66% | $818.14M | 0.6% |
| IWO | 56.56% | $11.60B | 0.24% |
| IWM | 56.00% | $63.72B | 0.19% |
| VTWO | 55.91% | $12.52B | 0.07% |
| KJAN | 55.86% | $287.30M | 0.79% |
| PBE | 55.83% | $223.19M | 0.58% |
| PINK | 55.69% | $130.57M | 0.5% |
| FBT | 55.50% | $1.01B | 0.54% |
| SCHA | 55.33% | $17.26B | 0.04% |
| TMSL | 55.23% | $828.66M | 0.55% |
| QQQJ | 55.15% | $621.52M | 0.15% |
| ESML | 55.03% | $1.84B | 0.17% |
| ISCG | 55.00% | $681.20M | 0.06% |
| NUSC | 54.99% | $1.14B | 0.31% |
| BBH | 54.86% | $330.62M | 0.35% |
| Name | Correlation | AUM | Expense Ratio |
|---|---|---|---|
| TAIL | -45.14% | $99.63M | 0.59% |
| VIXY | -41.79% | $164.54M | 0.85% |
| BTAL | -40.63% | $296.22M | 1.43% |
| IVOL | -17.98% | $347.03M | 1.02% |
| FTSD | -14.14% | $231.81M | 0.25% |
| XHLF | -12.83% | $1.73B | 0.03% |
| XONE | -12.79% | $625.28M | 0.03% |
| CLIP | -10.96% | $1.51B | 0.07% |
| TBLL | -10.93% | $2.13B | 0.08% |
| UTWO | -10.80% | $379.52M | 0.15% |
| TPMN | -10.12% | $30.70M | 0.65% |
| GBIL | -10.11% | $6.37B | 0.12% |
| SHYM | -10.09% | $357.13M | 0.35% |
| SPTS | -9.77% | $5.80B | 0.03% |
| BILS | -9.75% | $3.81B | 0.1356% |
| SCHO | -8.81% | $11.03B | 0.03% |
| VGSH | -8.24% | $22.80B | 0.03% |
| UNG | -7.97% | $360.54M | 1.06% |
| IBTG | -6.85% | $1.92B | 0.07% |
| ULST | -6.84% | $654.75M | 0.2% |
| Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
|---|---|---|---|---|
| CBOE | -11.18% | $24.23B | +35.36% | 1.09% |
| LITB | -10.88% | $21.24M | -78.57% | 0.00% |
| CYCN | -9.35% | $10.59M | +46.35% | 0.00% |
| CCRN | -7.30% | $429.13M | -3.89% | 0.00% |
| KR | -6.71% | $46.43B | +38.38% | 1.85% |
| ED | -6.62% | $36.00B | +12.64% | 3.34% |
| CNC | -6.25% | $16.81B | -49.40% | 0.00% |
| DFDV | -5.98% | $300.56M | +2,130.16% | 0.00% |
| EXC | -5.22% | $43.33B | +23.58% | 3.62% |
| AWK | -4.62% | $27.36B | +9.65% | 2.21% |
| K | -4.49% | $27.76B | +41.17% | 2.85% |
| VHC | -4.27% | $48.19M | +108.24% | 0.00% |
| CME | -3.91% | $99.39B | +40.68% | 3.86% |
| STG | -3.75% | $30.78M | -22.51% | 0.00% |
| HUSA | -3.35% | $19.66M | -19.53% | 0.00% |
| NEUE | -3.32% | $61.24M | +29.92% | 0.00% |
| VSA | -3.14% | $8.67M | -19.04% | 0.00% |
| ZCMD | -2.21% | $29.55M | -8.59% | 0.00% |
| DG | -2.08% | $25.41B | -7.95% | 2.05% |
| AEP | -1.09% | $55.16B | +17.93% | 3.54% |
Current Value
$16.121 Year Return
Current Value
$16.121 Year Return
